Catabasis Pharmaceuticals, Inc.
- Jurisdiction
United States - ISIN
US14875P2065 (CATB )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
Profile
Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. Read full profile
Stock price
Fundamentals
No data available
Dividends
No dividend payouts
Earnings Calls
Latest earnings call: March 10, 2020